South Korea Non-alcoholic Steatohepatitis Biomarkers Market Size & Outlook

The non-alcoholic steatohepatitis biomarkers market in South Korea is expected to reach a projected revenue of US$ 117.0 million by 2030. A compound annual growth rate of 25.6% is expected of South Korea non-alcoholic steatohepatitis biomarkers market from 2022 to 2030.
Revenue, 2021 (US$M)
$15.1
Forecast, 2030 (US$M)
$117.0
CAGR, 2022 - 2030
25.5%
Report Coverage
South Korea

South Korea non-alcoholic steatohepatitis biomarkers market, 2018-2030 (US$M)

South

Related Markets

South Korea non-alcoholic steatohepatitis biomarkers market highlights

  • The South Korea non-alcoholic steatohepatitis biomarkers market generated a revenue of USD 15.1 million in 2021 and is expected to reach USD 117.0 million by 2030.
  • The South Korea market is expected to grow at a CAGR of 25.6% from 2022 to 2030.
  • In terms of segment, serum biomarkers was the largest revenue generating type in 2021.
  • Hepatic Fibrosis Biomarkers is the most lucrative type segment registering the fastest growth during the forecast period.


Non-alcoholic steatohepatitis biomarkers market data book summary

Market revenue in 2021USD 15.1 million
Market revenue in 2030USD 117.0 million
Growth rate25.6% (CAGR from 2021 to 2030)
Largest segmentSerum biomarkers
Fastest growing segmentHepatic Fibrosis Biomarkers
Historical data2018 - 2020
Base year2021
Forecast period2022 - 2030
Quantitative unitsRevenue in USD million
Market segmentationSerum Biomarkers, Hepatic Fibrosis Biomarkers, Apoptosis Biomarkers, Oxidative Stress Biomarkers
Key market players worldwideGenfit SA, Siemens AG, Quest Diagnostics Inc, AstraZeneca PLC, Meridian Bioscience, Labcorp Holdings Inc, Pfizer Inc, Bristol-Myers Squibb Co


Other key industry trends

  • In terms of revenue, South Korea accounted for 1.8% of the global non-alcoholic steatohepatitis biomarkers market in 2021.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, Japan non-alcoholic steatohepatitis biomarkers market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 113.7 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Non-alcoholic Steatohepatitis Biomarkers Market Companies

Name Profile # Employees HQ Website

South Korea non-alcoholic steatohepatitis biomarkers market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non-alcoholic steatohepatitis biomarkers market will help companies and investors design strategic landscapes.


Serum biomarkers was the largest segment with a revenue share of 33.11% in 2021. Horizon Databook has segmented the South Korea non-alcoholic steatohepatitis biomarkers market based on serum biomarkers, hepatic fibrosis biomarkers, apoptosis biomarkers, oxidative stress biomarkers covering the revenue growth of each sub-segment from 2018 to 2030.


As per the Korean Biomedical Review, the South Korea nonalcoholic steatohepatitis biomarkers market is still at a nascent stage, and the industry needs support from the government to develop further to meet the rising demand for personalized medicine in the country.

As per Biological Research Information Centre (BRIC), majority of the laboratories and businesses are highly dependent on imported products and equipment from foreign companies to provide services in the country.

Domestic players are highly focused on genomic biomarkers while the industry is moving toward in vitro diagnostics. Similarly, companion diagnostics also have great growth potential. JW Bioscience, Aptamer Sciences, Genomictree, and WellMarker Bio are actively involved in development of predictive biomarkers in the country.

Reasons to subscribe to South Korea non-alcoholic steatohepatitis biomarkers market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of South Korea non-alcoholic steatohepatitis biomarkers market databook

  • Our clientele includes a mix of non-alcoholic steatohepatitis biomarkers market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the South Korea non-alcoholic steatohepatitis biomarkers market , including forecasts for subscribers. This country databook contains high-level insights into South Korea non-alcoholic steatohepatitis biomarkers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

South Korea non-alcoholic steatohepatitis biomarkers market size, by type, 2018-2030 (US$M)

South Korea Non-alcoholic Steatohepatitis Biomarkers Market Outlook Share, 2021 & 2030 (US$M)

South Korea non-alcoholic steatohepatitis biomarkers market size, by type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more